Filing Details

Accession Number:
0001104659-22-085790
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-03 21:48:50
Reporting Period:
2020-08-01
Accepted Time:
2022-08-03 21:48:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1641640 Nabriva Therapeutics Plc NBRV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1383292 Jr A Charles Rowland 414 Commerce Drive
Suite 120
Fort Washington PA 19034
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2022-08-01 8,496 $0.18 15,277 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct